What is the appropriate management for a 56-year-old female with concentric left ventricular hypertrophy, mild global left ventricular hypokinesia (involving the left anterior descending territory), left ventricular ejection fraction 50%, mild aortic and mitral regurgitation, grade I diastolic dysfunction, recent resolved chest pain, hypertension, and a single kidney?

Immediate Cardiac Ischemia Evaluation is Critical

This patient requires urgent evaluation for acute coronary syndrome (ACS) given the recent chest pain 4 days ago and echocardiographic findings of mild global LV hypokinesia predominantly in the LAD territory with reduced LVEF of 50%. The combination of chest pain, regional wall motion abnormalities, and reduced ejection fraction strongly suggests a recent ischemic event that demands immediate investigation.

Acute Management Priority

1. Rule Out Recent Myocardial Infarction

• Obtain high-sensitivity cardiac troponin immediately - the chest pain 4 days ago with LAD territory hypokinesia is highly suspicious for recent MI
• Perform 12-lead ECG looking for:
  • Q waves in anterior leads (V1-V4)
  • ST-T wave changes suggesting recent ischemia
  • Evidence of prior infarction
• Consider cardiac biomarkers (troponin, CK-MB) even though 4 days have elapsed

2. Coronary Artery Disease Assessment

Invasive coronary angiography is indicated given:

• Symptoms of angina with objective evidence of ischemia (regional wall motion abnormality)
• Decreased LV systolic function (LVEF 50%)
• Female >40 years with cardiovascular risk factors (hypertension) 1

The presence of LAD territory hypokinesia with chest pain history makes this a Class IC indication for coronary angiography 1. Do not delay this evaluation.

Blood Pressure Management Strategy

Target Blood Pressure

Target BP <130/80 mmHg given:

• Single kidney (chronic kidney disease equivalent) 2
• Left ventricular hypertrophy 2
• Reduced LVEF (50%) with evidence of cardiac dysfunction

Antihypertensive Medication Selection

Initiate ACE inhibitor or ARB as first-line therapy 2, 3. This recommendation is based on:

• Presence of LVH: ACE inhibitors, ARBs, long-acting CCBs, or thiazide diuretics are all appropriate initial choices 2
• Single kidney status: ACE inhibitor preferred for renoprotection 2
• Reduced LVEF (50%): ACE inhibitors provide mortality benefit in systolic dysfunction 2

Critical caveat for single kidney: Monitor renal function and potassium closely when initiating ACE inhibitor/ARB, as single kidney patients are at higher risk for:

• Hyperkalemia
• Acute kidney injury
• Worsening renal function 2

If ACE inhibitor is not tolerated, use ARB 2. If blood pressure remains uncontrolled, add:

• Thiazide diuretic (if eGFR adequate) 2
• Loop diuretic if volume overload present (given diastolic dysfunction) 2
• Long-acting dihydropyridine CCB as additional therapy 2

Avoid direct arterial vasodilators (hydralazine, minoxidil) as they do not promote LVH regression and may worsen outcomes 2, 3.

Valvular Disease Surveillance

The mild aortic and mitral regurgitation require monitoring but do not require intervention at this stage 1:

• Repeat echocardiography every 1-2 years to assess progression
• Monitor for symptoms (dyspnea, exercise intolerance)
• Intervention only indicated if severe AR develops with symptoms or LVEF <50% (already at threshold) 1

Heart Failure Management

With LVEF 50%, grade 1 diastolic dysfunction, and mild global hypokinesia:

• Initiate guideline-directed medical therapy (GDMT) if ischemia is confirmed
• ACE inhibitor/ARB already recommended above
• Consider beta-blocker if coronary disease confirmed (post-MI benefit) 4
• Aldosterone antagonist may be considered if LVEF remains ≤40% or symptoms develop 2

Single Kidney Considerations

Special monitoring requirements:

• Baseline and serial creatinine/eGFR measurements
• Potassium monitoring (especially with ACE inhibitor/ARB)
• Avoid nephrotoxic agents
• Ensure adequate hydration before any contrast procedures
• Consider N-acetylcysteine prophylaxis before coronary angiography

Immediate Action Algorithm

1. Today: High-sensitivity troponin, ECG, comprehensive metabolic panel
2. If troponin elevated or ECG changes: Admit for ACS management, urgent cardiology consultation
3. If troponin negative: Outpatient stress testing or coronary angiography within 1-2 weeks given wall motion abnormality
4. Simultaneously: Initiate ACE inhibitor (low dose initially given single kidney), monitor renal function in 1 week
5. Follow-up: Titrate antihypertensive to target <130/80 mmHg, repeat echo in 3-6 months to assess LV function and valvular disease

Critical Pitfalls to Avoid

• Do not dismiss the chest pain as "resolved" - LAD territory hypokinesia suggests significant ischemic event occurred
• Do not aggressively lower BP acutely if recent MI - avoid precipitous drops that could worsen ischemia 2
• Do not use combination ACE inhibitor + ARB in single kidney patient - increased risk of hyperkalemia and renal dysfunction 2
• Do not overlook renal function monitoring when starting RAAS blockade in single kidney
• Do not attribute all findings to hypertension alone - the regional wall motion abnormality pattern is not typical of pure hypertensive heart disease

The constellation of recent chest pain, LAD territory dysfunction, and reduced LVEF in a hypertensive patient with single kidney requires aggressive ischemia evaluation while carefully managing blood pressure and protecting remaining renal function.